<DOC>
	<DOCNO>NCT02069457</DOCNO>
	<brief_summary>Several study confirm patient cirrhosis possess imbalance procoagulant versus anticoagulant activity due increase factor VIII decrease protein C. Moreover , last two decade increase recognition bleeding also thrombosis complicate clinical course cirrhosis . The prevalence pathogenesis portal vein thrombosis ( PVT ) patient cirrhosis without hepatocellular carcinoma clearly define . The Aim study ass prevalence portal vein thrombosis patient cirrhosis without hepatocellular carcinoma , prospectively assess risk factor , outcome , prognosis patient . The investigator plan enroll two hundred patient liver cirrhosis . The patient go follow one year evaluate baseline every 6 month liver function test , coagulation test , upper abdomen ultrasound . All relevant clinical event evaluate every follow .</brief_summary>
	<brief_title>Prevalence Predictive Factors Portal Vein Thrombosis Patients With Cirrhosis</brief_title>
	<detailed_description />
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Venous Thrombosis</mesh_term>
	<criteria>Cirrhosis etiology severity , Aged 1880 year , Signed Informed Consent . Hepatocellular carcinoma , intrahepatic/extrahepatic cancer , document history congenital coagulation disorder , pregnancy , human immunodeficiency virus ( HIV ) positivity , recent ( &lt; 7 ) transfusion blood product , use anticoagulant/antiaggregation drug past 10 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>